Finance

Lists
5VA:FRA
Vaxcyte Inc
€48.40
-0.82%
(-0.40) 1D
Sep 11, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 5VA...
Open
€48.40
High
€48.40
Low
€48.40
Mkt. cap
8.85B
Avg. vol.
1.00
Volume
0.00
52-wk high
€55.00
52-wk low
€24.80
No. of employees
507
Open
€48.40
High
€48.40
Low
€48.40
Mkt. cap
8.85B
Avg. vol.
1.00
Volume
0.00
52-wk high
€55.00
52-wk low
€24.80
No. of employees
507
About Vaxcyte Inc
CEO-
Employees507
Founded2013
HeadquartersSan Carlos, California, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
209.93M
242.06M
312.78M
267.85M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
32.45M
32.22M
33.07M
34.92M
Operating expense
242.38M
274.28M
345.85M
302.78M
Total operating expenses
242.38M
274.28M
345.85M
302.78M
Operating income
-242.38M
-274.28M
-345.85M
-302.78M
Other non operating income
291.00K
1.32M
-1.38M
-7.28M
EBT including unusual items
-212.83M
-246.51M
-320.62M
-284.30M
EBT excluding unusual items
-212.83M
-246.51M
-320.62M
-284.30M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-212.83M
-246.51M
-320.62M
-284.30M
Net profit margin
-
-
-
-
Earnings per share
-1.56
-1.80
-2.30
-1.97
Interest and investment income
29.26M
26.45M
26.61M
25.76M
Interest expense
-
-
-
-
Net interest expenses
29.26M
26.45M
26.61M
25.76M
Depreciation and amortization charges
-
-
-
-
EBITDA
-239.32M
-266.79M
-342.90M
-299.78M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps